BXTAccelyon Blog

February 16, 2017

The ASCENDE-RT (Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy) study was the first randomized clinical trial comparing brachytherapy to the traditional use of external beam radiation therapy to treat intermediate and high risk Prostate Cancer patients over a period of between 6 to 9 years. The results show a significant increase in survival rates with an average of 50% of patients showing progression free survival when treated with LDR brachytherapy.

Please reload

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon
  • Black YouTube Icon
Featured Posts